322 related articles for article (PubMed ID: 29755453)
1. CLEC10A Is a Specific Marker for Human CD1c
Heger L; Balk S; Lühr JJ; Heidkamp GF; Lehmann CHK; Hatscher L; Purbojo A; Hartmann A; Garcia-Martin F; Nishimura SI; Cesnjevar R; Nimmerjahn F; Dudziak D
Front Immunol; 2018; 9():744. PubMed ID: 29755453
[TBL] [Abstract][Full Text] [Related]
2. Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation.
Dillon SM; Rogers LM; Howe R; Hostetler LA; Buhrman J; McCarter MD; Wilson CC
J Immunol; 2010 Jun; 184(12):6612-21. PubMed ID: 20483758
[TBL] [Abstract][Full Text] [Related]
3. FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo.
Ding Y; Wilkinson A; Idris A; Fancke B; O'Keeffe M; Khalil D; Ju X; Lahoud MH; Caminschi I; Shortman K; Rodwell R; Vuckovic S; Radford KJ
J Immunol; 2014 Feb; 192(4):1982-9. PubMed ID: 24453245
[TBL] [Abstract][Full Text] [Related]
4. Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease.
Kassianos AJ; Wang X; Sampangi S; Muczynski K; Healy H; Wilkinson R
Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1391-401. PubMed ID: 24049150
[TBL] [Abstract][Full Text] [Related]
5. Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c
Lu Y; Xu W; Gu Y; Chang X; Wei G; Rong Z; Qin L; Chen X; Zhou F
Front Immunol; 2019; 10():2829. PubMed ID: 31921114
[TBL] [Abstract][Full Text] [Related]
6. Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness.
Hémont C; Neel A; Heslan M; Braudeau C; Josien R
J Leukoc Biol; 2013 Apr; 93(4):599-609. PubMed ID: 23341538
[TBL] [Abstract][Full Text] [Related]
7. An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides.
Eggink LL; Roby KF; Cote R; Kenneth Hoober J
J Immunother Cancer; 2018 Apr; 6(1):28. PubMed ID: 29665849
[TBL] [Abstract][Full Text] [Related]
8. Acute aerobic exercise induces a preferential mobilisation of plasmacytoid dendritic cells into the peripheral blood in man.
Brown FF; Campbell JP; Wadley AJ; Fisher JP; Aldred S; Turner JE
Physiol Behav; 2018 Oct; 194():191-198. PubMed ID: 29763678
[TBL] [Abstract][Full Text] [Related]
9. CD141⁺ myeloid dendritic cells are enriched in healthy human liver.
Kelly A; Fahey R; Fletcher JM; Keogh C; Carroll AG; Siddachari R; Geoghegan J; Hegarty JE; Ryan EJ; O'Farrelly C
J Hepatol; 2014 Jan; 60(1):135-42. PubMed ID: 23968887
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.
Cooles FAH; Anderson AE; Skelton A; Pratt AG; Kurowska-Stolarska MS; McInnes I; Hilkens CMU; Isaacs JD
Front Immunol; 2018; 9():755. PubMed ID: 29867920
[TBL] [Abstract][Full Text] [Related]
11. Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions.
Yin X; Yu H; Jin X; Li J; Guo H; Shi Q; Yin Z; Xu Y; Wang X; Liu R; Wang S; Zhang L
J Immunol; 2017 Feb; 198(4):1553-1564. PubMed ID: 28087664
[TBL] [Abstract][Full Text] [Related]
12. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.
Jongbloed SL; Kassianos AJ; McDonald KJ; Clark GJ; Ju X; Angel CE; Chen CJ; Dunbar PR; Wadley RB; Jeet V; Vulink AJ; Hart DN; Radford KJ
J Exp Med; 2010 Jun; 207(6):1247-60. PubMed ID: 20479116
[TBL] [Abstract][Full Text] [Related]
13. Circulating CD1c(+) DCs are superior at activating Th2 responses upon Phl p stimulation compared with basophils and pDCs.
Rydnert F; Lundberg K; Greiff L; Lindstedt M
Immunol Cell Biol; 2014 Jul; 92(6):557-60. PubMed ID: 24687020
[TBL] [Abstract][Full Text] [Related]
14. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
15. Subsets of CD1c
Heger L; Hofer TP; Bigley V; de Vries IJM; Dalod M; Dudziak D; Ziegler-Heitbrock L
Front Immunol; 2020; 11():559166. PubMed ID: 33101275
[TBL] [Abstract][Full Text] [Related]
16. The clinical application of cancer immunotherapy based on naturally circulating dendritic cells.
Bol KF; Schreibelt G; Rabold K; Wculek SK; Schwarze JK; Dzionek A; Teijeira A; Kandalaft LE; Romero P; Coukos G; Neyns B; Sancho D; Melero I; de Vries IJM
J Immunother Cancer; 2019 Apr; 7(1):109. PubMed ID: 30999964
[TBL] [Abstract][Full Text] [Related]
17. Functionally Mature CD1c
Canavan M; Marzaioli V; Bhargava V; Nagpal S; Gallagher P; Hurson C; Mullan R; Veale DJ; Fearon U
Front Immunol; 2021; 12():745226. PubMed ID: 34691053
[TBL] [Abstract][Full Text] [Related]
18. A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.
Sittig SP; Bakdash G; Weiden J; Sköld AE; Tel J; Figdor CG; de Vries IJ; Schreibelt G
Mediators Inflamm; 2016; 2016():3605643. PubMed ID: 27057096
[TBL] [Abstract][Full Text] [Related]
19. Human blood dendritic cell subsets exhibit discriminative pattern recognition receptor profiles.
Lundberg K; Rydnert F; Greiff L; Lindstedt M
Immunology; 2014 Jun; 142(2):279-88. PubMed ID: 24444310
[TBL] [Abstract][Full Text] [Related]
20. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
Makino K; Long MD; Kajihara R; Matsueda S; Oba T; Kanehira K; Liu S; Ito F
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
